NGNE Sale Disclosure
Cvijic Christine Mikail · SEC Form 4 · Filed Jul 7, 2026
Sale
Calculated transaction value
$21.61K
Cvijic Christine Mikail President And CFO
NGNE
Neurogene
NGNE
Transaction date
Jul 6, 2026
Public filing date
Jul 8, 2026
Filing lag
Filed 2 days later
NGNE daily price context
Close on/before transaction
$32.56
Jul 6, 2026
Close before public filing
$36.8
Jul 7, 2026
Return since public filing
+4.97%
Through Aug 21, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 600 shares @ $36.02
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001543663-26-000017
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$173.38K
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Neurogene Inc. NGNE | Sale | Jul 7, 2026 | $151.76K |
| Neurogene Inc. NGNE Current | Sale | Jul 6, 2026 | $21.61K |